Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicskin Holdings has the GF Score of 54, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Medicskin Holdings
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Medicskin Holdings GF Score Related Terms
HKSE:08307 vs HCA, THC, DVA: GF Score Comparison
For the Medical Care Facilities subindustry, Medicskin Holdings's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicskin Holdings GF Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicskin Holdings's GF Score distribution charts can be found below:
* The bar in red indicates where Medicskin Holdings's GF Score falls into.
Medicskin Holdings (HKSE:08307) has a GF Score of 54 as of Aug. 12, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Medicskin Holdings and its competitors. This is 26% above median its historical median of 43.00. Over the past decade, Medicskin Holdings' GF Score has ranged from 15.00 to 58.00.
Is Medicskin Holdings' GF Score too high?
Medicskin Holdings' current GF Score of 54 is 26% above median its 10-year median of 43.00. Over the past 10 years, this metric has ranged from a low of 15.00 to a high of 58.00. Overall, Medicskin Holdings has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medicskin Holdings' GF Score compare to HCA and THC?
Medicskin Holdings' GF Score of 54 can be compared against companies in the Healthcare Providers & Services industry. Historically, Medicskin Holdings' own GF Score has ranged from 15.00 to 58.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Medicskin Holdings and its competitors. Medicskin Holdings's current GF Score is 54, which is 26% above median its own 10-year median of 43.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicskin Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medicskin Holdings (HKSE:08307) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.18, compared to a current price of HK$0.12 — trading 31.7% below its estimated fair value. The current GF Score is 54, which is 26% above median its 10-year median of 43.00. Medicskin Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Medicskin Holdings (HKSE:08307), the current GF Score is 54 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicskin Holdings (HKSE:08307) Overvalued in 2026?
Based on GuruFocus' analysis, Medicskin Holdings stock appears to be undervalued.
The current stock price of HK$0.12 is trading 31.7% below its estimated GF Value™ of HK$0.18.
GuruFocus considers Medicskin Holdings to be Possible Value Trap.
Key valuation signals for HKSE:08307:
GF Score: 54 (26% above median its 10-year median of 43.00)
GF Value™: HK$0.18 vs. price of HK$0.12 (31.7% below fair value)
No single metric tells the full story. See the HKSE:08307 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicskin Holdings Ltd is a medical skin care service provider. It is engaged in providing services for inter alia, acne, pigmentation, rosacea, dermatitis, eczema and warts, skin rejuvenation, facial sculpturing and body contouring, treatment for acne scars and enlarged pores, removal of undesirable naevi, and hair removal. The company operates through a single segment namely Consultation Service, Prescription and Dispensing Service, and Treatment Services. The company offers services throughout Hong Kong.
54GF Score
Get the complete analysis for HKSE:08307
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08307 has been successfully added to your 
